These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Organ culture studies of human prostatic adenocarcinomas. Mistry D; Weaver JP; Riches A Prostate; 1983; 4(3):307-14. PubMed ID: 6844161 [TBL] [Abstract][Full Text] [Related]
4. Response of men with advanced prostatic carcinoma to exogenous administration of testosterone. Prout GR; Brewer WR Cancer; 1967 Nov; 20(11):1871-8. PubMed ID: 4168724 [No Abstract] [Full Text] [Related]
5. Effect of stilboestrol and testosterone on the incorporation of 75selenomethionine by prostatic carcinoma cells. Ferro MA; Heinemann D; Smith PJ; Symes MO Br J Urol; 1988 Aug; 62(2):166-72. PubMed ID: 2970273 [TBL] [Abstract][Full Text] [Related]
6. Effect of hormones on the growth of virus-transformed hamster prostatic tissue. Fraley EE; Paulson DF Surg Forum; 1968; 19():544-5. PubMed ID: 4304976 [No Abstract] [Full Text] [Related]
7. Generalized bleeding following the treatment of prostatic carcinoma with testosterone and radioactive phosphorus. Ellman L J Urol; 1973 Sep; 110(3):331-2. PubMed ID: 4725740 [No Abstract] [Full Text] [Related]
8. An organ-culture technique for the investiation of hormonal dependence in human prostatic neoplasia. McMahon MJ; Thomas GH Br J Surg; 1970 Nov; 57(11):860. PubMed ID: 4098286 [No Abstract] [Full Text] [Related]
9. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma. Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814 [TBL] [Abstract][Full Text] [Related]
10. [Prostatic cancer and its prognosis under Honvan treatment]. Gaca A; Köhnlein HE; Köttgen H Med Welt; 1968 Apr; 15():961-7. PubMed ID: 5717752 [No Abstract] [Full Text] [Related]
11. Management of adenocarcinoma of prostate with diethylstilbestrol diphosphate and cyclophosphamide. Sinclair GR; Lupu AN; de Kernion JB Urology; 1975 May; 5(5):665-8. PubMed ID: 48303 [TBL] [Abstract][Full Text] [Related]
12. Effect of diethylstilbestrol on plasma testosterone levels during 24 hours: study comparing doses of 1 and 5 mg. daily, and 1 mg. 3 times daily. Flores-Esteva J; Medina-Santillán R; Berea-Domínguez H; Villalpando-Casas JJ; Martínez-Romero MA; Navarrete LR; Martin-Lombard ME J Urol; 1980 Jun; 123(6):887-9. PubMed ID: 7382007 [TBL] [Abstract][Full Text] [Related]
13. Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma. Robinson MR; Thomas BS Br Med J; 1971 Nov; 4(5784):391-4. PubMed ID: 5124437 [TBL] [Abstract][Full Text] [Related]
15. [Effective hormone therapy of prostatic cancer with lung metastasis: 2 cases]. Miyabe N; Maeno K; Enami N; Harada H; Kawakura K Hinyokika Kiyo; 1989 May; 35(5):901-4. PubMed ID: 2801385 [TBL] [Abstract][Full Text] [Related]
16. Morphological changes of benign prostatic hyperplasia in culture. McMahon MJ; Thomas GH Br J Cancer; 1973 Apr; 27(4):323-35. PubMed ID: 4121823 [TBL] [Abstract][Full Text] [Related]
17. Androgen therapy in advanced carcinoma of the prostate. Morales A; Connolly JG; Bruce AW Can Med Assoc J; 1971 Jul; 105(1):71-2. PubMed ID: 5088479 [No Abstract] [Full Text] [Related]
18. Considerations for the use of testosterone with systemic chemotherapy in prostatic cancer. Fowler JE; Whitmore WF Cancer; 1982 Apr; 49(7):1373-7. PubMed ID: 7059952 [TBL] [Abstract][Full Text] [Related]
19. Stilphostrol therapy in 100 cases of prostatic carcinoma. Rohlf PL; Flocks RH J Iowa Med Soc; 1969 Dec; 59(12):1096-8. PubMed ID: 4187802 [No Abstract] [Full Text] [Related]
20. Carcinoma of prostate: response of plasma luteinizing hormone and testosterone to oestrogen therapy. Alder A; Burger H; Davis J; Dulmanis A; Hudson B; Sarfaty G; Straffon W Br Med J; 1968 Jan; 1(5583):28-30. PubMed ID: 5636740 [No Abstract] [Full Text] [Related] [Next] [New Search]